Skip to main content

Call for papers - Vasculogenesis and angiogenesis in vivo and in vitro

Guest Editors

Sara Baratchi, PhD, Baker Heart and Diabetes Institute, Australia
Tara Haas, PhD, York University, Canada
Mary Kathryn (M.K.) Sewell-Loftin, PhD, University of Alabama at Birmingham, USA

Submission Status: Open   |   Submission Deadline: 22 August 2025

White adipose tissue whole mount; visible are capillaries stained with Griffonia lectin (green), DsRed+ pericytes (red), and nuclei stained with DAPI (blue).BMC Biology is calling for submissions to our Collection on vasculogenesis and angiogenesis in vivo and in vitro. This Collection aims to bring together cutting-edge research that explores the cell and molecular mechanisms and therapeutic applications of blood vessel formation in health and disease. 

Submissions may include in vivo studies on vasculogenesis and angiogenesis during embryonic development, as well as during tissue repair and regeneration in adult organisms. In vitro studies on vasculogenesis and angiogenesis in organoids and vessels-on-a-chip with applications in cell therapy, regenerative medicine, and disease modeling are also encouraged. 

New Content ItemThis Collection supports and amplifies research related to SDG 3: Good Health & Well-being.

Meet the Guest Editors

Back to top

Sara Baratchi, PhD, Baker Heart and Diabetes Institute, Australia

A/Prof Sara Baratchi is the 5th Alice Baker and Eleanor Shaw Fellow and Lab Head at the Baker Heart and Diabetes Research Institute, and an Associate Professor at the Baker Department of Cardiometabolic Health, University of Melbourne. Her research develops advanced organ-on-a-chip models to study human blood vessels and heart valves, using microfabrication and microfluidic technologies. These models uncover molecular mechanisms of cellular responses to hemodynamic forces, advancing vascular biology and therapeutic screening. She has published over 75 high-impact papers, with over 3,819 citations and an h-index of 32, earning numerous prestigious awards and grants. Website.

Tara Haas, PhD, School of Kinesiology and Health Science, York University, Canada

Dr Tara L Haas is a Professor in the School of Kinesiology and Health Science at York University, Canada. She earned her PhD from University of Virginia and completed Postdoctoral training at Yale University.  As an independent investigator since 1999, Dr Haas has developed expertise in endothelial cell and pericyte biology and the process of forming new capillaries, angiogenesis. Her research is focused on molecular regulators of blood vessel growth and remodeling in skeletal muscle and adipose tissue, within the contexts of exercise, peripheral artery disease and obesity/diabetes. Research interests also include characterization of sex-dimorphic endothelial cell phenotypes and how these influence the capacity of cells to undergo vascular remodeling in response to biochemical and mechanical stimuli. Website.

Mary Kathryn (M.K.) Sewell-Loftin, PhD, Department of Biomedical Engineering & O'Neal Comprehensive Cancer Center, Heersink School of Medicine, University of Alabama at Birmingham, USA

Dr Sewell-Loftin received her BS/MS in Chemical Engineering from the University of Alabama, with a specialty in biomaterials, followed by a PhD in Biomedical Engineering from Vanderbilt University. Her post-doctoral training occurred at Washington University in St. Louis in both the Department of Biomedical Engineering and the Internal Medicine – Molecular Oncology Division. She joined the UAB faculty in the Department of Biomedical Engineering in 2020. Her work sits at the interface of cancer biology, mechanobiology, and tissue engineering to understand how forces generated within tissues alter cellular behaviors to control disease progression. Website.

About the Collection

White adipose tissue whole mount; visible are capillaries stained with Griffonia lectin (green), DsRed+ pericytes (red), and nuclei stained with DAPI (blue).BMC Biology is calling for submissions to our Collection on vasculogenesis and angiogenesis in vivo and in vitro. This Collection aims to bring together cutting-edge research that explores the cell and molecular mechanisms and therapeutic applications of blood vessel formation in health and disease. 

Submissions may include in vivo studies on vasculogenesis and angiogenesis during embryonic development, as well as during tissue repair and regeneration in adult organisms. In addition, we welcome contributions covering pathological vasculogenesis and angiogenesis, emphasizing the role of signaling molecules and cellular dynamics on disease onset and progression, and the use of advanced imaging techniques and genetic models. 

In vitro studies on vasculogenesis and angiogenesis in organoids and vessels-on-a-chip with applications in cell therapy, regenerative medicine, and disease modeling are also encouraged. Particularly those reporting improved vascularization, with implications for increased survival and integration of transplantable cellular grafts.

This Collection supports and amplifies research related to SDG 3: Good Health & Well-being.

Image credit: Emmanuel Nwadozi, Haas Lab, York University

There are currently no articles in this collection.

Submission Guidelines

Back to top

This Collection welcomes submission of original Research and Methodology Articles. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. Articles for this Collection should be submitted via our submission system, Snapp. During the submission process you will be asked whether you are submitting to a Collection, please select "Vasculogenesis and angiogenesis in vivo and in vitro" from the dropdown menu.

Articles will undergo the journal’s standard peer-review process and are subject to all of the journal’s standard policies. Articles will be added to the Collection as they are published.

The Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.